Copanlisib Impurity 15 | CAS 1032570-71-0 - Request Quote
Copanlisib Impurity 15
| SZ CAT No: | SZ-C104018 |
| CAS No | 1032570-71-0 |
| Mol.F. | C11H12N4O2 |
| Mol.Wt. | 232.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Copanlisib Impurity 15 is chemically 5-Amino-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-8-ol. Copanlisib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Copanlisib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Copanlisib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1032570-71-0
Purchase 1032570-71-0
Order 1032570-71-0
Enquire 1032570-71-0
price of 1032570-71-0
1032570-71-0 Supplier
1032570-71-0 Manufacturer
1032570-71-0 Exporter
buy high quality Copanlisib Impurity 15
Purchase Copanlisib Impurity 15
Copanlisib Impurity 15 suppliers
Copanlisib Impurity 15 manufacturers
Copanlisib Impurity 15 price
Order Copanlisib Impurity 15
Enquire Copanlisib Impurity 15
Copanlisib Impurity 15 cost
Copanlisib Impurity 15 Supplier
Copanlisib Impurity 15 Distributor
Copanlisib Impurity 15 for Method Validation
Copanlisib Reference Standard
Copanlisib Impurity 15 for ANDA Filing
Copanlisib Impurity 15 for Forced Degradation Studies
Copanlisib Impurity 15 Identification Standards
Copanlisib Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


